WallStSmart

Cementos Pacasmayo SAA ADR (CPAC)vsCemex SAB de CV ADR (CX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Cemex SAB de CV ADR generates 658% more annual revenue ($17.04B vs $2.25B). CPAC leads profitability with a 9.5% profit margin vs 2.8%. CX appears more attractively valued with a PEG of 0.11. CPAC earns a higher WallStSmart Score of 68/100 (B-).

CPAC

Strong Buy

68

out of 100

Grade: B-

Growth: 7.3Profit: 7.0Value: 7.3Quality: 5.0
Piotroski: 5/9Altman Z: 1.59

CX

Buy

59

out of 100

Grade: C

Growth: 4.7Profit: 5.0Value: 7.3Quality: 4.5
Piotroski: 4/9Altman Z: 1.48
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CPACUndervalued (+15.9%)

Margin of Safety

+15.9%

Fair Value

$12.95

Current Price

$12.54

$0.41 discount

UndervaluedFair: $12.95Overvalued
CXUndervalued (+19.1%)

Margin of Safety

+19.1%

Fair Value

$13.42

Current Price

$10.69

$2.73 discount

UndervaluedFair: $13.42Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CPAC5 strengths · Avg: 8.4/10
EPS GrowthGrowth
61.5%10/10

Earnings expanding 61.5% YoY

P/E RatioValuation
17.4x8/10

Attractively priced relative to earnings

Price/BookValuation
2.7x8/10

Reasonable price relative to book value

Operating MarginProfitability
24.4%8/10

Strong operational efficiency at 24.4%

Revenue GrowthGrowth
15.4%8/10

15.4% revenue growth

CX2 strengths · Avg: 10.0/10
PEG RatioValuation
0.1110/10

Growing faster than its price suggests

Price/BookValuation
1.2x10/10

Reasonable price relative to book value

Areas to Watch

CPAC3 concerns · Avg: 3.3/10
Altman Z-ScoreHealth
1.594/10

Distress zone — elevated risk

Market CapQuality
$1.07B3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.033/10

Elevated debt levels

CX4 concerns · Avg: 3.5/10
P/E RatioValuation
31.3x4/10

Premium valuation, high expectations priced in

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
3.9%3/10

ROE of 3.9% — below average capital efficiency

Profit MarginProfitability
2.8%3/10

2.8% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : CPAC

The strongest argument for CPAC centers on EPS Growth, P/E Ratio, Price/Book. Revenue growth of 15.4% demonstrates continued momentum. PEG of 1.13 suggests the stock is reasonably priced for its growth.

Bull Case : CX

The strongest argument for CX centers on PEG Ratio, Price/Book. Revenue growth of 12.2% demonstrates continued momentum. PEG of 0.11 suggests the stock is reasonably priced for its growth.

Bear Case : CPAC

The primary concerns for CPAC are Altman Z-Score, Market Cap, Debt/Equity.

Bear Case : CX

The primary concerns for CX are P/E Ratio, EPS Growth, Return on Equity. Thin 2.8% margins leave little buffer for downturns.

Key Dynamics to Monitor

CPAC profiles as a growth stock while CX is a value play — different risk/reward profiles.

CX carries more volatility with a beta of 0.83 — expect wider price swings.

CPAC is growing revenue faster at 15.4% — sustainability is the question.

CX generates stronger free cash flow (582M), providing more financial flexibility.

Bottom Line

CPAC scores higher overall (68/100 vs 59/100) and 15.4% revenue growth. CX offers better value entry with a 19.1% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cementos Pacasmayo SAA ADR

BASIC MATERIALS · BUILDING MATERIALS · USA

Cementos Pacasmayo SAA, a cement company, produces, distributes and sells cement and cement-related materials in Peru. The company is headquartered in Lima, Peru.

Cemex SAB de CV ADR

BASIC MATERIALS · BUILDING MATERIALS · USA

CEMEX, SAB de CV, produces, markets, distributes and sells cement, ready-mix concrete, aggregates, clinker and other construction materials worldwide. The company is headquartered in San Pedro Garza Garca, Mexico.

Want to dig deeper into these stocks?